Indication
Urea cycle disorder
2 clinical trials
2 products
Product
RAVICTIClinical trial
A Randomised, Controlled, Open-Label Parallel Arm Study of Safety, PK and Ammonia Control of RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid and Sodium Phenylbutyrate in Phenylbutyrate Treatment Naïve Patients With Urea Cycle DisordersStatus: Completed, Estimated PCD: 2022-07-05
Product
NaPBAClinical trial
An Open Label Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate (GPB; RAVICTI®) in Pediatric Subjects Under Two Years of Age With Urea Cycle Disorders (UCDs)Status: Completed, Estimated PCD: 2016-10-17